Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,037
Total Claims
$1.1M
Drug Cost
859
Beneficiaries
$1,335
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-5%
Cost per patient vs peers
$1,335 vs $1,411 avg
+5%
Brand preference vs peers
11.1% vs 10.6% avg
Brand vs Generic
Brand: 1,549 claims · $893K
Generic: 12,379 claims · $249K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 166 | $122K |
| Empagliflozin | 69 | $96K |
| Fluticasone/Umeclidin/Vilanter | 96 | $66K |
| Semaglutide | 50 | $59K |
| Rivaroxaban | 80 | $52K |
| Insulin Glargine,hum.Rec.Anlog | 75 | $44K |
| Linagliptin | 81 | $43K |
| Sitagliptin Phosphate | 20 | $31K |
| Exenatide Microspheres | 20 | $25K |
| Insulin Detemir | 22 | $22K |
| Budesonide/Formoterol Fumarate | 30 | $18K |
| Insulin Aspart | 13 | $17K |
| Mirabegron | 15 | $16K |
| Fluticasone Propion/Salmeterol | 24 | $15K |
| Insulin Glargine,hum.Rec.Anlog | 36 | $14K |
Prescribing Profile
Patient Profile
74
Avg Age
55%
Female
1.39
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data